Search Results for “”

We face an unbelievable scenario in the United States with the treatment of feline infectious peritonitis (FIP) , where our only option is to suggest clients meet up with strangers in parking lots to buy an unapproved medication to inject into their dying cats .  

A new study offers hope for treating hemangiosarcoma, the “silent killer” that often isn’t diagnosed until a seemingly healthy dog suffers from acute collapse due to a ruptured, bleeding tumor, usually on the spleen.

Veterinarians and techs are still in high demand in 2023. Expect higher salaries, signing bonuses, and more hesitance to sign noncompete agreements, according to Stacy Pursell of The Vet Recruiter.

Bexacat is the first oral drug treatment of diabetes in cats and offers an alternative to insulin injections—but veterinarians must choose the right patients due to important safety considerations.

A temporary relaxing of telemed rules in the UK is now set to become permanent, according to the RCVS. Here’s how that change could impact veterinarians on both sides of the pond. 

A proposal by the California Veterinary Medical Association to allow RVTs to establish veterinary-client-patient relationships was recently approved to enter the regulatory process.

Surgery to treat herniated discs in dogs can cost up to $12,000 and result in weeks of painful recovery for the patient . A clinical trial at Texas A&M is testing a nonsurgical outpatient treatment that is far less expensive and less invasive.

Nearly 40% of dogs show signs of canine osteoarthritis (OA), but many don’t receive treatment. That could change with the newly FDA-approved Librela, a monthly injectable that has been used by veterinarians in Europe for the past two years with largely positive results.

Mark Morris, Sr., DVM, the first president of AAHA, created the prototype for Hill’s K/D renal diet in his own kitchen. Today, the Morris Animal Foundation continues his legacy by funding pioneering research like the Golden Retriever Lifetime Study and the hemangiosarcoma initiative.

Ivan Zakharenkov, DVM, MBA, chief executive officer of Galaxy Vets, turned his own experience of burnout into a passion for ongoing research of mental health and wellbeing in the profession.